Introduction
Aneurysms arising from basilar perforators are extremely rare and since they were first described by Ghogawala et al. [1] in 1996 fewer than 50 cases have been published in the English literature [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . According to Aboukais et al. [2] these are aneurysms whose neck is entirely located on a perforator artery without direct involvement of the basilar trunk. More recently Satti et al. [18] proposed a three point classification based on the exact anatomical origin of the aneurysm:
Type I -the aneurysm arises from the basilar trunk adjacent to the perforating arterial branch but not involving a perforating artery Type IIa -aneurysms incorporating the origin of the perforating arteries Type IIb -aneurysms having the perforating artery arising from the dome of the aneurysm Type III -fusiform aneurysms arising beyond the parent vessel (basilar artery)
The rarity of these lesions means their natural history is unknown. Although conservative management, surgical and endovascular treatment strategies have been employed there is no consensus with regards to the optimal treatment strategy.
Here we present our experience of 9 cases and their treatment both conservatively and with flow diversion.
Patients and methods

Patient population
We retrospectively searched our prospectively maintained quality assurance database, for patients treated in our institution For each patient we recorded demographic data, clinical presentation, aneurysm size and location, therapeutic intervention, immediate angiographic and clinical result, as well as clinical and radiological follow-up information.
Endovascular treatment
All treatments were performed under general anaesthesia. The p64 flow diverter (phenox, Bochum, Germany), the p48 (phenox, Bochum, Germany) or the p48_HPC (phenox, Bochum, Germany) were used [19] . The p48_HPC is a newly developed surface modified flow diverter whereas the p64 and p48 are not surface modified. The surface modified p48_HPC is designed for use with only single anti-platelet medication. The selection of FDS was based on operator preference as well as the size of the parent vessel and blood load. Treatment with flow diversion was based upon the clinical status of the patient as well as after positive identification of the underlying aneurysm. Furthermore, we have used flow diverters treat small, ruptured saccular aneurysms and believe this to be a safer option than selective catheterisation and embolisation with coils or liquid embolics [20] .
Dependant upon the clinical state of the patient pre-medication was given either on table or orally at least 3 h prior to the operation for patients able to take oral medications. For patients able to take oral medications loading doses of aspirin (500 mg) and ticagrelor (180 mg) were given the morning of the surgery. The effectiveness of the anti-platelet medication was tested using both the VerifyNow (Accumetrics) and Multiplate (Roche Diagnostics) analysers to ensure adequate anti-aggregation prior to the operation and at least 3 h post-medication. For patients unable to take oral medication prior to the operation an intravenous bolus dose of weight adjusted eptifibatide was given on table. Subsequently loading doses of ticagrelor via NG tube (180 mg) and IV aspirin (500 mg) were given at the end of the procedure. In both situations the effectiveness of the anti-platelet medication was tested 24hrs post-procedure using the VerifyNow and Multiplate analysers. In patients in whom the p48_HPC was planned to be used only single anti-platelet medication with prasugrel 10 mg was prescribed and started 3 days prior to the treatment.
The post-procedural antiplatelet regimen consisted of ticagrelor (90 mg twice daily) or prasugrel (10 mg once daily) continued for 12 months following treatment and aspirin (100 mg once daily) continued for life. The patients treated with the p48_HPC were continued on 10 mg prasugrel alone.
The pre-operative brain imaging was carefully assessed to determine if an external ventricular drain (EVD) was required or may be required. Signs of obstructive hydrocephalus, intraventricular blood or evidence of raised intracranial pressure were used as markers to guide the insertion of an EVD. The EVD was inserted prior to the initiation of anti-platelet medication. Following insertion of the EVD repeat imaging was performed to assess both the positioning of the EVD and to exclude haemorrhage along the EVD tract. Anti-platelet medication was commenced only after haemorrhage following drain insertion had been excluded.
All procedures were performed via the right common femoral route using a 6Fr access system as standard. All procedures were performed under heparin anticoagulation with a 5000 IU bolus dose at the start of the procedure and subsequent 1000 IU bolus doses every hour to maintain the activated clotting time between 2 and 2.5 times the baseline.
Procedural assessment and follow-up
Patency and flow characteristics within the aneurysm and parent artery were assessed angiographically immediately after placement of the FDS and during follow-up. Follow-up axial imaging, either CT or MRI, were performed prior to the discharge of the patient. A CT angiogram was routinely performed if the patient developed signs or symptoms of post-hemorrhagic cerebral vasospasm.
Procedural follow-up was performed initially at 3-6 months, again at 9-12 months and then once per year. Standard angiographic projections were used to assess the patency of the vessels and the aneurysms in addition to angiographic projections that repeated those used during the treatment. Aneurysm occlusion was graded as either completely excluded, minor remnant, major remnant, or unchanged (patent) and additionally using the three point Raymond-Roy classification [21] .
Results
We identified 9 patients with an average age of 55 ± 9.7 years. The majority of the patients were male (n = 7, 78%). Each patient had a single aneurysm and there were no aneurysms identified elsewhere in the intracranial circulation. All of the aneurysms were 3 mm and the average maximum diameter of the aneurysm was 2.1 ± 0.5 mm (range 1-3 mm). According to the classification of Satti et al. two aneurysms were classified as type 1, one as type 2a, two as type 2b and the remaining four aneurysms were classified as type 3. One third of the aneurysms were not detected on the initial angiogram (Figs. 3 and 4) . Six of the aneurysms were treated with flow diversion and the remaining three aneurysms were managed conservatively. In three patients the p64 FDS was used and in one patient 2 p64 FDS's were deployed in a telescoping fashion to attain stasis in the aneurysm at the end of the procedure. In one patient the p48 FDS (Figs. 1 and 2) was used and in the remaining two patients treated with flow diversion a single p48_HPC was deployed. The p48_HPC flow diverter was used in patients with worse WFNS grade because of the larger blood load and poorer clinical state and single anti-platelet medication was thought to be safer. An EVD was inserted prior to the procedure and prior to the initiation of anti-aggregation in 5 patients (55.5%). In the remaining patients an EVD was not required.
In the patients treated with FDS there were no intra-operative complications and none of the aneurysms suffered from repeat haemorrhage. There was no evidence of perforator infarction on the follow-up post treatment imaging. In the three patients treated conservatively there was a single repeat haemorrhage and only at this point was the aneurysm positively identified. In the remaining two patients there was no repeat SAH. At the most recent follow up imaging, available in 7 patients (average 5.6 months, range 3-12 months) all of the aneurysms treated with flow diversion showed complete occlusion. In one of the conservatively managed aneurysms there was no significant change in the appearance of the aneurysm and no follow-up imaging was available for review in the remaining conservatively managed patient.
Clinical follow-up data was available in 8 patients with 6 achieving a good outcome (mRS 2) (75%). One patient was mRS 3 and the remaining patient died as a consequence of the repeat SAH (mRS 6). The results are summarised in Table 1 .
Discussion
Basilar artery perforator aneurysms (BAPA's) are rare lesions and their diagnosis requires a high level of suspicion. Even with a high degree of suspicion detection can be easily missed since the aneurysms are tiny, often partially thrombosed and fed by small calibre vessels [13, 15] . In our series 1/3 of the aneurysms were not detected on initial angiography and one of the aneurysms was only detected after a repeat haemorrhage that resulted in the death of the patient. Anatomically, BAPA's are small lesions with the vast majority (85%) of reported aneurysms being 3 mm in maximum diameter [14] . Given the small size of these aneurysms they can be easily missed on CT or MR imaging and therefore, cerebral angiography, using a meticulous technique, is mandatory and ideally this should include on table intra-arterial rotational angiography with a low threshold for repeat angiography should the initial angiogram be negative. In the recent publication of Finitsis et al. [14] the aneurysm was not seen on the initial angiogram in 61% of cases and the timing of this repeat angiogram is debatable [2, 3, 8, 15, 22] , however, we believe that a time interval of at least 72 h seems reasonable and Buell et al. [23] recommend repeat angiography be performed within 7 days. Given the difficulty with diagnosis it has been suggested that a proportion of perimesencephalic haemorrhages are actually related to the rupture of a BAPA that went undetected [3] , however, this has been disputed by others [14] .
The natural history of these lesions is unknown although it has been suggested that they have a more benign course than other ruptured aneurysms [3, 5] . Some authors have recommended an initial conservative approach [9, 23, 24] with some suggesting the addition of anti-fibrinolytic therapy [23] (Table 2) .
However, given that the re-haemorrhage rate is likely to be between 11 and 15% [14, 16] it seems reasonable to consider some form of treatment and both neurosurgical and endovascular treatment options (Table 3 ) have been reported. Although surgical exclusion of BAPA's has been performed it can be challenging [15] . It should also be noted that these aneurysms often arise from the distal basilar with nearly 50% (4/9) of our cases occurring between the SCA and the PCA where surgical access is particularly difficult. The distal basilar artery appears to be a more common location for BAPA's with 29 of the previously 46 (63%) cases occurring at the distal basilar artery. The exact cause for this is unknown especially given the greater number of perforator arteries arising from the mid-basilar [25] .
Furthermore, BAPA's may not be amenable to standard clip occlusion as there is no true neck therefore, the placement of a surgical clip may also occlude the perforator [22] and in the reported cases treated surgically only 25% of the parent vessel perforators were preserved (Table 3 ).
An endovascular approach has also been used to treat BAPA's ( Table 3 ). The first to describe an endovascular treatment was Chen and colleagues in 2012 [7] and options that have been used include endovascular coiling, the use of Onyx [8] , telescopic stenting [11, 18] and flow diversion [5, 12] . As these aneurysms are typically very small and/or arise from small perforating branches catheterisation of the aneurysm may be impossible. Furthermore, stability and the safe deployment of coils may be extremely difficult. Brinjikji et al. [26] recently published an article looking at the risks of coiling of small aneurysms ( 3 mm). In their own series intraprocedural haemorrhage occurred in 16.7% of ruptured cases. In the meta-analysis, data on 422 aneurysms, including 271 ruptured aneurysms, was analysed. The intra-procedural rupture rate for unruptured aneurysms was 5.0% (95% CI, 2.3%-10.4%) compared to 10.7% (95% CI, 7.4%-15.1%) in the ruptured aneurysms. Whilst this publication did not deal specifically with BAPA's it does high- light the fact that coiling of small aneurysms does come with nonnegligible risks. Similarly, although liquid embolics have been used the potential occlusion of the perforator or inadvertent embolisation of non-target vessels are significant. Alternatively, flow diversion can be used. In the recent publication of Satti et al. [18] two overlapping Enterprise stents (Codman, Raynham, Massachusetts, USA) were used to achieve stagnation of flow within the aneurysms which subsequently occluded and this strategy has been used previously [27] [28] [29] . Satti and colleagues chose Enterprise stents because of the presence of cerebral vasospasm at the time of treatment and their concerns for inappropriate sizing if a flow diverter was implanted. Whilst stents have been shown to relieve vasospasm [30] [31] [32] there is no evidence that flow diverter stents are able to do this. Other authors have implanted flow diverter stents with the first report published by Chalouhi et al. [5] in 2014 and using the Pipeline Embolisation Device (PED) (Medtronic, Dublin, Ireland). Subsequently, Peschillo et al. [12] and Finitsis et al. [14] described their experiences of using flow diverters to treat BAPA's.
From an anatomical perspective the basilar artery has features making it well suited for the deployment of flow diverters as it is generally straight and of uniform calibre with flow diverters of 3-3.5 mm used in all our cases. The principle concern is the occlusion of perforators [33] , however, the incidence of complications may be related to the underlying disease [34] and of the 5 cases previously published perforator infarction occurred in one patient despite dual anti-aggregation. We would advise implanting, Given that the haemorrhage is often mainly located in the posterior fossa we believe the insertion of an external ventricular drain (EVD) should be considered prior to the implantation of the flow diverter to minimise the risks of parenchymal haemorrhage should an EVD be required [35] [36] [37] . Our study is limited by its single centre, retrospective design and small numbers. Similarly, we are unsure if the results can be applied to all the different types of basilar perforator aneurysms and to other flow diverters.
Conclusion
Basilar artery perforator aneurysms are rare causes of subarachnoid haemorrhage. Flow diversion is a viable treatment strategy with a low risk of symptomatic perforator infarction and repeat haemorrhage.
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